Adamas Pharmaceuticals Overview

Adamas Pharmaceuticals Gross Profit

Gross Profit analysis for ADMS.

Quarterly Gross Profit

$25.32M

↑ 28.61% YoY

As of Sep 30, 2021

Annual Gross Profit (TTM)

$86.10M

↑ 26.78% YoY

Trailing 12 months ending Sep 30, 2021

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin